Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial

Authors:
  • FMFrançoise Mornex
    Françoise Mornex
  • JDJean-Yves Douillard
    Jean-Yves Douillard
  • EQElisabeth Quoix
    Elisabeth Quoix
  • VBVéronique Beckendorf
    Véronique Beckendorf
  • DGDominique Grunenwald
    Dominique Grunenwald
  • EAElodie Amour
    Elodie Amour
  • BMBernard Milleron
    Bernard Milleron

Abstract
No abstract available

This publication has 42 references indexed in Scilit: